Literature DB >> 25023148

Early spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes.

Xiaofei Chen1, Huanfen Zhou, Yan Gong, Shihui Wei, Maonian Zhang.   

Abstract

BACKGROUND: Microglial activation has been recognized as a neuropathological feature in diabetic retinopathy. But the early spatiotemporal characterization of microglial activation in the retina and the optic nerve of diabetic animals has not been fully investigated. The purpose of this study was to investigate early sequential changes of microglia in the retinas of rats with streptozotocin-induced diabetes. Microglia in the optic nerves of rats with streptozotocin-induced diabetes were also studied.
METHODS: In 4-week, 8-week, and 12-week diabetic and normal control rats, microglial activation in the retinas and optic nerves was evaluated by immunolabeling with OX-42 antibody. Density, proportion of activation, and laminar distribution of retinal microglia were quantified. The retinal mRNA level of Iba-1, a microglial-specific marker, was measured by real-time PCR.
RESULTS: The density of retinal microglia was not different between diabetic and control rats, but the proportion of activated microglia increased significantly in diabetic rats at each time point. The proportion of microglia increased obviously in the nerve fiber layer and the ganglion cell layer while decreasing in the inner plexiform layer in 12-week diabetic rats. Moreover, retinal Iba-1 mRNA expression increased in 8-week and 12-week diabetic rats. Processes of microglia in the optic nerves of control rats were aligned with the long axis of nerve fibers, while the alignment was disturbed in diabetic rats.
CONCLUSIONS: Morphology, proportion of activation, distribution, and mRNA expression of retinal microglia changed characteristically with the progression of the disease in early-stage diabetic rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25023148     DOI: 10.1007/s00417-014-2727-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

1.  Microglial changes accompanying the promotion of retinal ganglion cell axonal regeneration into peripheral nerve grafts.

Authors:  E Raibon; Y Sauvé; D A Carter; F Gaillard
Journal:  J Neurocytol       Date:  2002-01

Review 2.  Dynamic motility of microglia: purinergic modulation of microglial movement in the normal and pathological brain.

Authors:  Keiko Ohsawa; Shinichi Kohsaka
Journal:  Glia       Date:  2011-09-07       Impact factor: 7.452

Review 3.  Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.

Authors:  Yoon Seong Kim; Tong H Joh
Journal:  Exp Mol Med       Date:  2006-08-31       Impact factor: 8.718

4.  Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats.

Authors:  X X Zeng; Y K Ng; E A Ling
Journal:  Vis Neurosci       Date:  2000 May-Jun       Impact factor: 3.241

5.  Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease.

Authors:  M Chen; V O Ona; M Li; R J Ferrante; K B Fink; S Zhu; J Bian; L Guo; L A Farrell; S M Hersch; W Hobbs; J P Vonsattel; J H Cha; R M Friedlander
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

6.  Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy.

Authors:  J Kyle Krady; Anirban Basu; Colleen M Allen; Yuping Xu; Kathryn F LaNoue; Thomas W Gardner; Steven W Levison
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

7.  Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats.

Authors:  Emma Arnal; Maria Miranda; Siv Johnsen-Soriano; Raquel Alvarez-Nölting; Manuel Díaz-Llopis; Javier Araiz; Enrique Cervera; Francisco Bosch-Morell; Francisco J Romero
Journal:  Curr Eye Res       Date:  2009-11       Impact factor: 2.424

8.  Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria.

Authors:  Jinzhao Wang; Qingqing Wei; Cong-Yi Wang; William D Hill; David C Hess; Zheng Dong
Journal:  J Biol Chem       Date:  2004-03-05       Impact factor: 5.157

Review 9.  Microglia as a source and target of cytokines.

Authors:  Uwe-Karsten Hanisch
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

Review 10.  Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.

Authors:  Timothy S Kern
Journal:  Exp Diabetes Res       Date:  2007
View more
  15 in total

1.  Expression, distribution and function of kinin B1 receptor in the rat diabetic retina.

Authors:  Soumaya Hachana; Menakshi Bhat; Jacques Sénécal; Frédéric Huppé-Gourgues; Réjean Couture; Elvire Vaucher
Journal:  Br J Pharmacol       Date:  2018-02-13       Impact factor: 8.739

Review 2.  Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.

Authors:  Pedro Romero-Aroca; Marc Baget-Bernaldiz; Alicia Pareja-Rios; Maribel Lopez-Galvez; Raul Navarro-Gil; Raquel Verges
Journal:  J Diabetes Res       Date:  2016-09-28       Impact factor: 4.011

Review 3.  The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.

Authors:  Christine Altmann; Mirko H H Schmidt
Journal:  Int J Mol Sci       Date:  2018-01-01       Impact factor: 5.923

4.  Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy.

Authors:  Atsuhiro Kanda; Yoko Dong; Kousuke Noda; Wataru Saito; Susumu Ishida
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

Review 5.  Microglia in Retinal Degeneration.

Authors:  Khalid Rashid; Isha Akhtar-Schaefer; Thomas Langmann
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

Review 6.  Neurovascular Impairment and Therapeutic Strategies in Diabetic Retinopathy.

Authors:  Toshiyuki Oshitari
Journal:  Int J Environ Res Public Health       Date:  2021-12-31       Impact factor: 3.390

Review 7.  Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy.

Authors:  Jan M Keppel Hesselink; Ciro Costagliola; Josiane Fakhry; David J Kopsky
Journal:  J Ophthalmol       Date:  2015-11-18       Impact factor: 1.909

8.  Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1α-VEGF/VEGFR2 signaling pathway.

Authors:  Zengyang Yu; Tianyu Zhang; Chenyuan Gong; Yuchen Sheng; Bin Lu; Lingyu Zhou; Lili Ji; Zhengtao Wang
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

Review 9.  Microglia and Inflammatory Responses in Diabetic Retinopathy.

Authors:  Urbanus Muthai Kinuthia; Anne Wolf; Thomas Langmann
Journal:  Front Immunol       Date:  2020-11-06       Impact factor: 7.561

10.  Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy.

Authors:  Hai Xie; Chaoyang Zhang; Dandan Liu; Qian Yang; Lei Tang; Tianqin Wang; Haibin Tian; Lixia Lu; Jing-Ying Xu; Furong Gao; Juan Wang; Caixia Jin; Weiye Li; Guoxu Xu; Guo-Tong Xu; Jingfa Zhang
Journal:  Diabetologia       Date:  2020-10-26       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.